We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Notices of publication and a consolidated list of references of pre-Exit European Assessment Documents for construction products.
Product Safety Report for Skin Light with Shea Butter and Vitamin E Skin Lightening Body Lotion sold via eBay presenting a serious chemical risk.
Preliminary outbreak assessment for lumpy skin disease in Libya and East Asia.
Regulators must use this process guidance note (PGN) to assess applications and write permits for animal hide and skin processors.
This document contains a synopsis of causation occurring in Non Melanoma skin cancer.
The Medicines and Healthcare products Regulatory Agency (MHRA) is advising anyone experiencing skin redness or burning sensations after they have stopped using these creams or ointments to seek advice from their health professional before using these products again.
A new synthetic ‘skin’ has been developed that could be used to test new decontamination procedures
A new campaign to raise awareness of the fire risk and the precautions that need to be taken by users of skin creams has been launched today
The UK Health Security Agency (UKHSA) has issued further guidance to support people who have been diagnosed with monkeypox and advised to self-isolate at home.
Advise patients taking hydrochlorothiazide-containing products of the cumulative, dose-dependent risk of non-melanoma skin cancer, particularly in long-term use, and the need to regularly check for (and report) any suspicious skin lesions or moles. Counsel patients to limit exposure to sunlight...
Stop prescribing Picato and consider other treatment options for actinic keratosis as appropriate. The licence of ingenol mebutate (Picato) has been suspended as a precautionary measure while the European Medicines Agency (EMA) continues to investigate concerns about a possible increased...
Advise patients treated with ingenol mebutate gel to be vigilant for new skin lesions and to seek medical advice immediately should any occur. Use with caution in patients with a history of skin cancer.
May cause skin irritation, particularly in children with eczema, possibly due to sodium lauryl sulfate content.
Employment Appeal Tribunal judgment of Judge Eady on 18 January 2018.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.